✦ LIBER ✦

Anxiogenic effects of Sumatriptan in panic disorder: A double-blind, placebo-controlled study

✍ Scribed by Daniella Amital; Leah Fostick; Yehuda Sasson; Seth Kindler; Howard Amital; Joseph Zohar

Book ID: 118436634
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 84 KB
Volume: 15
Category: Article
ISSN: 0924-977X
DOI: 10.1016/j.euroneuro.2004.12.002

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Epinephrine infusions in Panic Disorder:

Epinephrine infusions in Panic Disorder: A double-blind placebo-controlled study

✍ Dirk J. Veltman; Gudo A. van Zijderveld; Richard van Dyck 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 807 KB

Serotonin function in panic disorder: a

Serotonin function in panic disorder: a double blind placebo controlled study with fluvoxamine and ritanserin

✍ Johan A. Boer; H. G. M. Westenberg 📂 Article 📅 1990 🏛 Springer 🌐 English ⚖ 1021 KB

Comparative effects of low and high dose

Comparative effects of low and high doses of clomipramine and placebo in panic disorder: a double-blind controlled study

✍ V. Caillard; F. Rouillon; J. F. Viel; S. Markabi 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 700 KB

Fluvoxamine in the treatment of panic di

Fluvoxamine in the treatment of panic disorder: a multi-center, double-blind, placebo-controlled study in outpatients

✍ Gregory M Asnis; Faiq A Hameedi; Andrew W Goddard; Steven G Potkin; Donald Black 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 135 KB

Sumatriptan Nasal Spray in Adolescent Mi

Sumatriptan Nasal Spray in Adolescent Migraineurs: A Randomized, Double-Blind, Placebo-Controlled, Acute Study

✍ Paul Winner; A. David Rothner; John D. Wooten; Chris Webster; Michael Ames 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 254 KB

Alprazolam in the treatment of generaliz

Alprazolam in the treatment of generalized anxiety and panic disorders: A double-blind placebo-controlled study

✍ G. Chouinard; L. Annable; R. Fontaine; L. Solyom 📂 Article 📅 1982 🏛 Springer 🌐 English ⚖ 472 KB

In a double-blind controlled study lasting 8 weeks, 50 anxious psychoneurotic outpatients with a primary diagnosis of generalized anxiety or panic disorder were randomly assigned to alprazolam (n = 30), a new benzodiazepine, or placebo (n = 20), after a washout period of 1 week. Alprazolam at dosage